Caroline Pirritt

468 total citations
5 papers, 369 citations indexed

About

Caroline Pirritt is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Caroline Pirritt has authored 5 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Caroline Pirritt's work include Growth Hormone and Insulin-like Growth Factors (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). Caroline Pirritt is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). Caroline Pirritt collaborates with scholars based in . Caroline Pirritt's co-authors include Mark J. Mulvihill, Elizabeth Buck, Maryland Rosenfeld-Franklin, Qunsheng Ji, Andrew Cooke, Lee D. Arnold, Neil W. Gibson, Matthew O’Connor, Darla Landfair and K.W. Foreman and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics and Future Medicinal Chemistry.

In The Last Decade

Caroline Pirritt

5 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline Pirritt	4	248	180	92	87	47	5	369
Darla Landfair	5	241 1.0×	107 0.6×	66 0.7×	75 0.9×	34 0.7×	8	370
Stephen Hillerman United States	4	241 1.0×	132 0.7×	105 1.1×	118 1.4×	80 1.7×	5	427
Toru Hanamura Japan	14	151 0.6×	121 0.7×	106 1.2×	203 2.3×	121 2.6×	38	500
Xinwei Yun China	11	345 1.4×	133 0.7×	147 1.6×	99 1.1×	36 0.8×	21	509
Jason L. Rowand United States	5	251 1.0×	50 0.3×	62 0.7×	125 1.4×	80 1.7×	6	369
Enrica Antonia Martino Italy	12	183 0.7×	87 0.5×	38 0.4×	121 1.4×	24 0.5×	60	417
Kati Servan Germany	6	224 0.9×	51 0.3×	105 1.1×	119 1.4×	24 0.5×	6	389
Krista Menard United States	6	188 0.8×	97 0.5×	90 1.0×	168 1.9×	62 1.3×	9	373
Dingyuan Luo China	13	201 0.8×	81 0.5×	140 1.5×	73 0.8×	38 0.8×	22	354
Qing-Yun Chong Singapore	14	280 1.1×	51 0.3×	184 2.0×	140 1.6×	109 2.3×	16	472

Countries citing papers authored by Caroline Pirritt

Since Specialization

Citations

This map shows the geographic impact of Caroline Pirritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Pirritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Pirritt more than expected).

Fields of papers citing papers by Caroline Pirritt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Pirritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Pirritt. The network helps show where Caroline Pirritt may publish in the future.

Co-authorship network of co-authors of Caroline Pirritt

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Pirritt. A scholar is included among the top collaborators of Caroline Pirritt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Pirritt. Caroline Pirritt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Mulvihill, Mark J., Andrew Cooke, Maryland Rosenfeld-Franklin, et al.. (2009). Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor. Future Medicinal Chemistry. 1(6). 1153–1171. 240 indexed citations

2.

Rosenfeld-Franklin, Maryland, Caroline Pirritt, Alexander Cooke, et al.. (2008). Antitumor efficacy of OSI-930 and the molecular targeted agent erlotinib in preclinical xenograft models. Journal of Clinical Oncology. 26(15_suppl). 14596–14596. 2 indexed citations

3.

Ji, Qunsheng, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, et al.. (2007). A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo. Molecular Cancer Therapeutics. 6(8). 2158–2167. 118 indexed citations

4.

Rosenfeld-Franklin, Maryland, Caroline Pirritt, Darla Landfair, et al.. (2007). In vivo evaluation of OSI-906, a novel small molecule kinase inhibitor of the insulin-like growth factor-1 receptor (IGF-1R). Molecular Cancer Therapeutics. 6. 5 indexed citations

5.

Ji, Qunsheng, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, et al.. (2007). Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials. Molecular Cancer Therapeutics. 6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact